Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000799698-14-000014
Filing Date
2014-08-06
Accepted
2014-08-05 17:46:07
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTER 2, 2014 FORM 10-Q form10-q.htm 10-Q 530599
2 CERTIFICATION OF CEO exh31-1.htm EX-31.1 13376
3 CERTIFICATION OF CFO exh31-2.htm EX-31.2 12626
4 CERTIFICATION OF CEO exh32-1.htm EX-32.1 8990
5 CERTIFICATION OF CFO exh32-2.htm EX-32.2 9078
  Complete submission text file 0000799698-14-000014.txt   4181618

Data Files

Seq Description Document Type Size
6 cytr-20140630.xml EX-101.INS 527519
7 cytr-20140630.xsd EX-101.SCH 35902
8 cytr-20140630_cal.xml EX-101.CAL 27605
9 cytr-20140630_def.xml EX-101.DEF 136809
10 cytr-20140630_lab.xml EX-101.LAB 444121
11 cytr-20140630_pre.xml EX-101.PRE 239144
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
CYTRX CORP (Filer) CIK: 0000799698 (see all company filings)

EIN.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15327 | Film No.: 141017347
SIC: 2836 Biological Products, (No Diagnostic Substances)